Evidence map›Paper›PMID 20041292›Full record

ArticleGlycoconjugate journal2010

Cytotoxicity and enzymatic activity inhibition in cell lines treated with novel iminosugar derivatives.

Mercè Padró, José A Castillo, Livia Gómez, Jesús Joglar, Pere Clapés, Carme de Bolós

Abstract read
PubMed Publisher
In one paragraph

Article in Glycoconjugate journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mercè PadróPrograma de Recerca en Càncer, IMIM-Hospital del Mar (PRBB), Dr. Aiguader, 88, 08003 Barcelona, Spain.
José A Castillo
Livia Gómez
Jesús Joglar
Pere Clapés
Carme de Bolós
Consejo Superior de Investigaciones Científicas · ESHospital Del Mar · ESMunicipal Institute for Medical Research · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iminosugars are monosaccharide analogues that have been demonstrated to be specific inhibitors for glycosidases and are currently used therapeutically in several human disorders. N-alkylated derivatives of D-fagomine and (2R,3S,4R,5S)-2-(hydroxymethyl)-5-methylpyrrolidine-3,4-diol with aliphatic chains were tested in eight human cancer cell lines to analyze their cytotoxicity and the inhibitory effect in the activities of specific glycosidases. Results indicate that these compounds were more cytotoxic as the length of the alkyl chain increases. N-dodecyl-D-fagomine inhibited specifically the alpha-D-glucosidase activity in cell lysates, whereas no effect was detected in other glycosidases. The N-dodecyl derivative of (2R,3S,4R,5S)-2-(Hydroxymethyl)-5-methylpyrrolidine-3,4-diol induced specific inhibition against alpha-L-fucosidase in cell lysates. Our results indicated that the length of the alkyl chain linked to the iminosugars determine their cytotoxicity as well as the inhibitory effect on the enzymatic activities of specific glycosidases, in human cancer cell lines.

Indexed as

Cell DeathCell ExtractsCell Line, TumorCell SurvivalGlucosidesGlycoside HydrolasesGlycosidesHumansImino PyranosesPhenotypePyrrolidines(2S,3S,4R,5S)-5-methylpyrrolidine-3,4-diol4-nitrophenyl alpha-glucoside4-nitrophenylfucosideCell ExtractsfagomineGlucosidesGlycoside HydrolasesGlycosidesImino PyranosesPyrrolidines

Identifiers

PMID20041292
OpenAlexW2126730944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.